OFSA3 fundamentals
Key facts
Ourofino SA engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals. It operates through the following segments: Production Animals, Companion Animals, and International Operations. The Production Animals segment focuses in the sale of domestic market of veterinary drugs, vaccines, and other products for cattle, pigs, poultry, sheep, horses, and goats. The Companion Animals segment sell veterinary drugs and other products for dogs and cats. The International Operations offers veterinary drugs, vaccines, and products for production and companion animals in Latin American countries. The company was founded by Norival Bonamichi and Jardel Massari in 1987 and is headquartered in Cravinhos, Brazil.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company